T48.6 Poisoning by, adverse effect of and underdosing of antiasthmatics, not elsewhere classified

Name of the Condition

• Poisoning by, adverse effect of and underdosing of antiasthmatics, not elsewhere classified

Summary

This condition encompasses poisoning, adverse effects, or underdosing of antiasthmatic medications not classified elsewhere. It includes clinical outcomes from exposure to these agents, whether due to accidental or intentional overdose, therapeutic errors, or insufficient dosing.

Causes

Exposure to antiasthmatics can result from accidental ingestion, incorrect administration, drug interactions, or intentional misuse. Underdosing may occur from dosing errors, patient non-adherence, or pharmacokinetic factors affecting drug levels.

Risk Factors

• Use of medications with narrow therapeutic windows (e.g., certain bronchodilators or anti-inflammatory agents).
• Lack of proper storage or labeling of medications.
• History of substance misuse or accidental exposure in vulnerable populations.
• Concurrent use of multiple drugs with overlapping respiratory effects.
• Renal or hepatic impairment affecting drug metabolism.

Symptoms

• Worsening or uncontrolled asthma symptoms (e.g., wheezing, shortness of breath).
• Excessive bronchodilation (e.g., tachycardia, tremors, palpitations).
• Nausea, vomiting, or gastrointestinal distress.
• Dizziness, headache, or altered mental status.
• Signs of underdosing, such as persistent respiratory symptoms despite therapy.

Diagnosis

Clinical evaluation focuses on symptoms, medication history, and dosage details. Laboratory tests may assess drug levels or organ function. Pulmonary function tests or monitoring of respiratory status might be used to confirm effects.

Treatment Options

• Discontinuation or adjustment of the offending agent.
• Supportive care (e.g., oxygen therapy, bronchodilators, or antiemetics).
• Management of specific toxic effects (e.g., cardiac monitoring for tachyarrhythmias).
• Addressing underdosing by optimizing therapeutic regimens.

Prognosis and Follow-Up

Prognosis depends on the severity of exposure, timeliness of treatment, and underlying health. Most cases resolve with appropriate management, but severe poisoning may require intensive care. Follow-up includes monitoring respiratory function and medication adherence.

Complications

• Respiratory failure or exacerbation of asthma.
• Cardiovascular instability (e.g., tachycardia, hypertension).
• Metabolic disturbances (e.g., electrolyte imbalances).
• Long-term respiratory or cardiac sequelae in severe cases.

Lifestyle & Prevention

• Proper storage and labeling of antiasthmatic medications.
• Education on correct dosing and administration.
• Avoidance of drug interactions (e.g., with other respiratory or cardiac agents).
• Regular review of medication regimens with healthcare providers.

When to Seek Professional Help

Seek immediate medical attention for severe respiratory distress, chest pain, or altered consciousness. Contact a provider for persistent symptoms or concerns about medication efficacy or side effects.

Tips for Medical Coders

Document the specific antiasthmatic agent involved, the nature of the event (poisoning, adverse effect, or underdosing), and any contributing factors (e.g., dosing errors, interactions). Ensure clinical details support the classification and differentiate from other respiratory or toxic exposures.